102 related articles for article (PubMed ID: 11536045)
21. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro analysis of the human tissue-type plasminogen activator gene promoter in neuroblastomal cell lines: evidence for a functional upstream kappaB element.
Lux W; Klobeck HG; Daniel PB; Costa M; Medcalf RL; Schleuning WD
J Thromb Haemost; 2005 May; 3(5):1009-17. PubMed ID: 15869598
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
25. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
26. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters.
Burnett E; Christensen J; Tattersall P
J Mol Biol; 2001 Dec; 314(5):1029-39. PubMed ID: 11743720
[TBL] [Abstract][Full Text] [Related]
27. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
28. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
Barber MC; Vallance AJ; Kennedy HT; Travers MT
Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
[TBL] [Abstract][Full Text] [Related]
29. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): A rapid method to screen for and analyze methylation.
Bianco T; Hussey D; Dobrovic A
Hum Mutat; 1999; 14(4):289-93. PubMed ID: 10502775
[TBL] [Abstract][Full Text] [Related]
30. DNA modifications repaired by base excision repair are epigenetic.
Moore SP; Toomire KJ; Strauss PR
DNA Repair (Amst); 2013 Dec; 12(12):1152-8. PubMed ID: 24216087
[TBL] [Abstract][Full Text] [Related]
31. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
[TBL] [Abstract][Full Text] [Related]
32. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
[TBL] [Abstract][Full Text] [Related]
33. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.
Rice JC; Ozcelik H; Maxeiner P; Andrulis I; Futscher BW
Carcinogenesis; 2000 Sep; 21(9):1761-5. PubMed ID: 10964110
[TBL] [Abstract][Full Text] [Related]
34. Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes.
Huang D; Shipman-Appasamy PM; Orten DJ; Hinrichs SH; Prystowsky MB
Mol Cell Biol; 1994 Jun; 14(6):4233-43. PubMed ID: 7910946
[TBL] [Abstract][Full Text] [Related]
35. A polymerase chain reaction-based method for constructing a linear vector with site-specific DNA methylation.
Arakawa T; Ohta T; Abiko Y; Okayama M; Mizoguchi I; Takuma T
Anal Biochem; 2011 Sep; 416(2):211-7. PubMed ID: 21669180
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter.
Rice JC; Futscher BW
Nucleic Acids Res; 2000 Sep; 28(17):3233-9. PubMed ID: 10954590
[TBL] [Abstract][Full Text] [Related]
37. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity.
Sunahori K; Juang YT; Tsokos GC
J Immunol; 2009 Feb; 182(3):1500-8. PubMed ID: 19155497
[TBL] [Abstract][Full Text] [Related]
38. 53BP1 is a positive regulator of the BRCA1 promoter.
Rauch T; Zhong X; Pfeifer GP; Xu X
Cell Cycle; 2005 Aug; 4(8):1078-83. PubMed ID: 15970701
[TBL] [Abstract][Full Text] [Related]
39. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.
Kino T; Takeshima H; Nakao M; Nishi T; Yamamoto K; Kimura T; Saito Y; Kochi M; Kuratsu J; Saya H; Ushio Y
Genes Cells; 2001 May; 6(5):441-54. PubMed ID: 11380622
[TBL] [Abstract][Full Text] [Related]
40. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
